Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis
- PMID: 24812352
- DOI: 10.1161/CIRCRESAHA.114.302761
Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis
Abstract
Chronic inflammation in response to lipoprotein accumulation in the arterial wall is central in the development of atherosclerosis. Both innate and adaptive immunity are involved in this process. Adaptive immune responses develop against an array of potential antigens presented to effector T lymphocytes by antigen-presenting cells, especially dendritic cells. Functional analysis of the role of different T-cell subsets identified the Th1 responses as proatherogenic, whereas regulatory T-cell responses exert antiatherogenic activities. The effect of Th2 and Th17 responses is still debated. Atherosclerosis is also associated with B-cell activation. Recent evidence established that conventional B-2 cells promote atherosclerosis. In contrast, innate B-1 B cells offer protection through secretion of natural IgM antibodies. This review discusses the recent development in our understanding of the role of T- and B-cell subsets in atherosclerosis and addresses the role of dendritic cell subpopulations in the control of adaptive immunity.
Keywords: B-lymphocytes; T-lymphocytes; antibodies; cardiovascular disease; dendritic cells.
Similar articles
-
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.Nat Rev Cardiol. 2011 Jun;8(6):348-58. doi: 10.1038/nrcardio.2011.62. Epub 2011 Apr 19. Nat Rev Cardiol. 2011. PMID: 21502963 Review.
-
Adaptive Response of T and B Cells in Atherosclerosis.Circ Res. 2016 Feb 19;118(4):668-78. doi: 10.1161/CIRCRESAHA.115.306427. Circ Res. 2016. PMID: 26892965 Review.
-
Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.Immunobiology. 2016 Sep;221(9):1014-33. doi: 10.1016/j.imbio.2016.05.010. Epub 2016 May 24. Immunobiology. 2016. PMID: 27262513 Review.
-
The role of T and B cells in human atherosclerosis and atherothrombosis.Clin Exp Immunol. 2015 Feb;179(2):173-87. doi: 10.1111/cei.12477. Clin Exp Immunol. 2015. PMID: 25352024 Free PMC article. Review.
-
MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity.Circulation. 2014 Oct 14;130(16):1363-73. doi: 10.1161/CIRCULATIONAHA.114.011090. Epub 2014 Sep 15. Circulation. 2014. PMID: 25223984 Free PMC article.
Cited by
-
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Cytokine Growth Factor Rev. 2015 Dec;26(6):673-85. doi: 10.1016/j.cytogfr.2015.04.003. Epub 2015 May 12. Cytokine Growth Factor Rev. 2015. PMID: 26005197 Free PMC article. Review.
-
Myeloid BAF60a deficiency alters metabolic homeostasis and exacerbates atherosclerosis.Cell Rep. 2023 Oct 31;42(10):113171. doi: 10.1016/j.celrep.2023.113171. Epub 2023 Sep 27. Cell Rep. 2023. PMID: 37768825 Free PMC article.
-
The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection.Mediators Inflamm. 2018 Mar 19;2018:6587296. doi: 10.1155/2018/6587296. eCollection 2018. Mediators Inflamm. 2018. PMID: 29743811 Free PMC article. Review.
-
Insights into the toxicological effects of nanomaterials on atherosclerosis: mechanisms involved and influence factors.J Nanobiotechnology. 2023 Apr 28;21(1):140. doi: 10.1186/s12951-023-01899-y. J Nanobiotechnology. 2023. PMID: 37118804 Free PMC article. Review.
-
Profiles of Immune Cell Infiltration in Carotid Artery Atherosclerosis Based on Gene Expression Data.Front Immunol. 2021 Mar 25;12:599512. doi: 10.3389/fimmu.2021.599512. eCollection 2021. Front Immunol. 2021. PMID: 33841393 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical